Wanbury Limited
Sukhpal Singh is an accomplished professional with extensive experience in marketing and sales within the pharmaceutical industry. Currently serving as General Manager of Marketing and Sales at Maxzimaa Pharmaceuticals Pvt Ltd and also as Head of Marketing and Sales for Nutriva at Zydus Group, Sukhpal Singh has held key leadership roles in companies such as Wanbury Limited, Jubilant Life Sciences Ltd, Sanofi India Ltd, Panacea Biotec Ltd, and Ranbaxy. Notable achievements include overseeing the gynecology division at Wanbury, managing the Critical Care portfolio at Jubilant Life Sciences, and driving significant sales growth at Sanofi. Sukhpal Singh holds a Bachelor's Degree in Medical from Delhi University and an MBA in Marketing.
This person is not in the org chart
This person is not in any teams
Wanbury Limited
Corporate Profile Towards Better Healthcare… Wanbury Limited, one of India’s fastest growing pharmaceutical companies amongst the ‘Top 50 Companies’ in India (as per ORG-IMS), has a strong presence in API global market and domestic branded Formulation. Wanbury’s major thrust area lies in Active Pharmaceutical Ingredient (API) sale in over 70 countries and Pan-India Formulation presence. Active Pharmaceutical Ingredient : Wanbury has a basket of over 13 API products. It is the largest manufacturer of Metformin with over 8500 tons per year. It is the largest exporter of Tramadol to the US market. Wanbury exports to over 50 countries, 65% of which comprises of regulated markets. Has two US-FDA approved multi-product API facilities and one plant under operation for semi-regulated markets. Has been the preferred supplier to some of the top five generic players of the world. Formulations : -Pan-India presence in ethical formulations with a portfolio of close to 70 brands. -Strong presence in gynecology, orthopedics, heamatinics, anti-diabetic, neutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics and general practitioner.